Metformin monotherapy versus dual therapy with metformin and a dipeptidyl peptidase-IV inhibitor for treatment of type 2 diabetes mellitus: a systematic review and meta-analysis

被引：0
|
作者：
Tobin-Schnittger, P. [1 ]
Ong, G. [2 ]
O'Brien, T. [2 ,4 ]
Liew, A. [2 ,3 ,4 ]
机构：
[1] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Portiuncula Univ Hosp, Ballinasloe, Ireland
[4] Natl Univ Ireland Galway, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P75
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis
    Min, Se Hee
    Yoon, Jeong-Hwa
    Hahn, Seokyung
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 893 - 902
  • [22] To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus
    Andres, Julia
    Yeo, Jia Xuan
    Khoo, Chin Meng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S123 - S124
  • [23] Systematic review and meta-analysis of efficacy and safety of combinational therapy with metformin and dipeptidyl peptidase-4 inhibitors
    Alanazi, Abdulrahman S.
    SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (06) : 603 - 613
  • [24] A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin
    Kim, Hun-Sung
    Shin, Jeong-Ah
    Lee, Seung-Hwan
    Kim, Eun-Sook
    Cho, Jae-Hyoung
    Son, Ho-Young
    Yoon, Kun-Ho
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (10) : 810 - 816
  • [25] Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
    Karagiannis, Thomas
    Paschos, Paschalis
    Paletas, Konstantinos
    Matthews, David R.
    Tsapas, Apostolos
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [26] Metformin therapy and cognitive dysfunction in patients with type 2 diabetes A meta-analysis and systematic review
    Zhang, Qing-Qing
    Li, Wen-Shan
    Liu, Zhou
    Zhang, Hui-Li
    Ba, Ying-Gui
    Zhang, Rui-Xia
    MEDICINE, 2020, 99 (10) : E19378
  • [27] Clinical effect of metformin in children and adolescents with type 2 diabetes mellitus: A systematic review and meta-analysis
    Al-Shareef, Mohammed A.
    Sanneh, Abdoulie F. N. S.
    Aljoudi, Abdullah S.
    JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2012, 19 (02): : 68 - 73
  • [28] Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Zhang, Kui
    Bai, Peng
    Dai, Hao
    Deng, Zhenhua
    PRIMARY CARE DIABETES, 2021, 15 (01) : 52 - 58
  • [29] Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
    Wang, Fei
    He, Yuan
    Zhang, Rong
    Zeng, Qiang
    Zhao, Xiaolan
    MEDICINE, 2017, 96 (36)
  • [30] Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
    Skandalis, K.
    Spirova, M.
    Gaitanis, G.
    Tsartsarakis, A.
    Bassukas, I. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) : 249 - 253
12345